The effects of artificial- and stevia-based sweeteners on lipid profile in adults: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials

References

• Adaramoye, O. A., and O. O. Akanni. 2016. Effects of long-term administration of aspartame on biochemical indices, lipid profile and redox status of cellular system of male rats. Journal of Basic and Clinical Physiology and Pharmacology 27 (1):29–37.
   PubMedGoogle Scholar
• Ajami, M., M. Seyfi, FaP. Hosseini, P. Naseri, A. Velayati, F. Mahmoudnia, M. Zahedirad, and M. Hajifaraji. 2020. Effects of stevia on glycemic and lipid profile of type 2 diabetic patients: A randomized controlled trial. Avicenna Journal of Phytomedicine 10 (2):118–27.
   PubMed Web of Science ®Google Scholar
• Anker, C. C. B., S. Rafiq, and P. B. Jeppesen. 2019. Effect of steviol glycosides on human health with emphasis on type 2 diabetic biomarkers: A systematic review and meta-analysis of randomized controlled trials. Nutrients 11 (9):1965.
   PubMed Web of Science ®Google Scholar
• Asbaghi, O., F. Naeini, D. Ashtary-Larky, S. Moradi, N. Zakeri, E. Eslampour, M. R. Kelishadi, and A. A. Naeini. 2021. Effects of chromium supplementation on lipid profile in patients with type 2 diabetes: A systematic review and dose-response meta-analysis of randomized controlled trials. Journal of Trace Elements in Medicine and Biology 66:126741. doi: 10.1016/j.jtemb.2021.126741.
   PubMed Web of Science ®Google Scholar
• Azeez, O. H., S. Y. Alkass, and D. S. Persike. 2019. Long-term saccharin consumption and increased risk of obesity, diabetes, hepatic dysfunction, and renal impairment in rats. Medicina 55 (10):681. doi: 10.3390/medicina55100681.
   PubMedGoogle Scholar
• Bansal, V., A. Mottalib, T. K. Pawar, N. Abbasakoor, E. Chuang, A. Chaudhry, M. Sakr, R. A. Gabbay, and O. Hamdy. 2018. Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: Impact on 30-day readmission rate and hospital cost. BMJ Open Diabetes Research and Care 6 (1): e000460. doi: 10.1136/bmjdrc-2017-000460.
   PubMed Web of Science ®Google Scholar
• Barriocanal, L. A., M. Palacios, G. Benitez, S. Benitez, J. T. Jimenez, N. Jimenez, and V. Rojas. 2008. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in type 1 and type 2 diabetics. Regulatory Toxicology and Pharmacology 51 (1):37–41. doi: 10.1016/j.yrtph.2008.02.006.
   PubMed Web of Science ®Google Scholar
• Beverly, J. K., and M. J. Budoff. 2020. Atherosclerosis: Pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. Journal of Diabetes 12 (2):102–4.
   PubMed Web of Science ®Google Scholar
• Campos, V., C. Despland, V. Brandejsky, R. Kreis, P. Schneiter, A. Chiolero, C. Boesch, and L. Tappy. 2015. Sugar‐and artificially sweetened beverages and intrahepatic fat: A randomized controlled trial. Obesity 23 (12):2335–9. doi: 10.1002/oby.21310.
   PubMed Web of Science ®Google Scholar
• Chan, P., B. Tomlinson, Y. J. Chen, J. C. Liu, M. H. Hsieh, and J. T. Cheng. 2000. A double‐blind placebo‐controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. British Journal of Clinical Pharmacology 50 (3):215–20. doi: 10.1046/j.1365-2125.2000.00260.x.
   PubMed Web of Science ®Google Scholar
• Cheng, Y.-C., J.-M. Sheen, W. L. Hu, and Y.-C. Hung. 2017. Polyphenols and oxidative stress in atherosclerosis-related ischemic heart disease and stroke. Oxidative Medicine and Cellular Longevity 2017:8526438. doi: 10.1155/2017/8526438.
   PubMed Web of Science ®Google Scholar
• Dávila, L. A., J. L. Miranda, D. A. Camargo, K. P. Zuleta, M. U. González, V. C. Nava, S. D. Agüero, and N. R. Villasmil. 2017. Glycemic index, glycemic load and insulin response of two formulas of isoglucose with different sweeteners and dietary fiber in healthy adults and type-2 diabetes. Nutricion Hospitalaria 34 (3):532–9.
   PubMed Web of Science ®Google Scholar
• Enani, S., S. Bahijri, M. Malibary, H. Jambi, B. Eldakhakhny, J. Al-Ahmadi, R. Al Raddadi, G. Ajabnoor, A. Boraie, and J. Tuomilehto. 2020. The association between dyslipidemia, dietary habits and other lifestyle indicators among non-diabetic attendees of primary health care centers in Jeddah, Saudi Arabia. Nutrients 12 (8):2441. doi: 10.3390/nu12082441.
   PubMed Web of Science ®Google Scholar
• Fagherazzi, G., A. Vilier, D. Saes Sartorelli, M. Lajous, B. Balkau, and F. Clavel-Chapelon. 2013. Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the etude epidémiologique auprès des femmes de la mutuelle générale de l’education nationale–European prospective investigation into cancer and nutrition cohort. The American Journal of Clinical Nutrition 97 (3):517–23. doi: 10.3945/ajcn.112.050997.
   PubMed Web of Science ®Google Scholar
• Ferri, L. A., W. Alves‐Do‐Prado, S. S. Yamada, S. Gazola, M. R. Batista, and R. B. Bazotte. 2006. Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension. Phytotherapy Research 20 (9):732–6. doi: 10.1002/ptr.1944.
   PubMed Web of Science ®Google Scholar
• Gordon, H., A. Oxman, G. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H. Schünemann, and GRADE Working Group. 2008. Rating quality of evidence and strength of recommendations: Grade: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (7650):924–6. doi: 10.1136/bmj.39489.470347.AD.
   PubMedGoogle Scholar
• Han, Y., E.-Y. Kwon, M. K. Yu, S. J. Lee, H.-J. Kim, S.-B. Kim, Y. H. Kim, and M.-S. Choi. 2018. A preliminary study for evaluating the dose-dependent effect of d-allulose for fat mass reduction in adult humans: A randomized, double-blind, placebo-controlled trial. Nutrients 10 (2):160. doi: 10.3390/nu10020160.
   PubMed Web of Science ®Google Scholar
• Hedayatnia, M., Z. Asadi, R. Zare-Feyzabadi, M. Yaghooti-Khorasani, H. Ghazizadeh, R. Ghaffarian-Zirak, A. Nosrati-Tirkani, M. Mohammadi-Bajgiran, M. Rohban, F. Sadabadi, et al. 2020. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids in Health and Disease 19 (1):1–11. doi: 10.1186/s12944-020-01204-y.
   PubMed Web of Science ®Google Scholar
• Hess, E. L., E. A. Myers, S. E. Swithers, and V. E. Hedrick. 2018. Associations between nonnutritive sweetener intake and metabolic syndrome in adults. Journal of the American College of Nutrition 37 (6):487–93.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., D. G. Altman, P. C. Gøtzsche, P. Jüni, D. Moher, A. D. Oxman, J. Savović, K. F. Schulz, L. Weeks, J. A. Sterne, et al. 2011a. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343 (oct18 2):d5928. doi: 10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., D. G. Altman, and J. A. Sterne. 2011b. Chapter 8: Assessing risk of bias in included studies. In Cochrane handbook for systematic reviews of interventions, Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org
   Google Scholar
• Higgins, K. A., R. V. Considine, and R. D. Mattes. 2018. Aspartame consumption for 12 weeks does not affect glycemia, appetite, or body weight of healthy, lean adults in a randomized controlled trial. The Journal of Nutrition 148 (4):650–7. doi: 10.1093/jn/nxy021.
   PubMed Web of Science ®Google Scholar
• Higgins, K. A., and R. D. Mattes. 2019. A randomized controlled trial contrasting the effects of 4 low-calorie sweeteners and sucrose on body weight in adults with overweight or obesity. The American Journal of Clinical Nutrition 109 (5):1288–301. doi: 10.1093/ajcn/nqy381.
   PubMed Web of Science ®Google Scholar
• Hozo, S. P., B. Djulbegovic, and I. Hozo. 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 5 (1):1–10. doi: 10.1186/1471-2288-5-13.
   PubMedGoogle Scholar
• Hsieh, M.-H., P. Chan, Y.-M. Sue, J.-C. Liu, T. H. Liang, T.-Y. Huang, B. Tomlinson, M. S. S. Chow, P.-F. Kao, and Y.-J. Chen. 2003. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: A two-year, randomized, placebo-controlled study. Clinical Therapeutics 25 (11):2797–808. doi: 10.1016/S0149-2918(03)80334-X.
   PubMed Web of Science ®Google Scholar
• Hurtubise, J., K. Mclellan, K. Durr, O. Onasanya, D. Nwabuko, and J. F. Ndisang. 2016. The different facets of dyslipidemia and hypertension in atherosclerosis. Current Atherosclerosis Reports 18 (12):1–12. doi: 10.1007/s11883-016-0632-z.
   PubMed Web of Science ®Google Scholar
• Leon, A. S., D. B. Hunninghake, C. Bell, D. K. Rassin, and T. R. Tephly. 1989. Safety of long-term large doses of aspartame. Archives of Internal Medicine 149 (10):2318–24.
   PubMedGoogle Scholar
• Leroith, D. 2007. Dyslipidemia and glucose dysregulation in overweight and obese patients. Clinical Cornerstone 8 (3):38–52.
   PubMedGoogle Scholar
• Liu, S., J. E. Manson, M. J. Stampfer, M. D. Holmes, F. B. Hu, S. E. Hankinson, and W. C. Willett. 2001. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. The American Journal of Clinical Nutrition 73 (3):560–6. doi: 10.1093/ajcn/73.3.560.
   PubMed Web of Science ®Google Scholar
• Madjd, A., M. A. Taylor, A. Delavari, R. Malekzadeh, I. A. Macdonald, and H. R. Farshchi. 2017. Beneficial effects of replacing diet beverages with water on type 2 diabetic obese women following a hypo‐energetic diet: A randomized, 24‐week clinical trial. Diabetes, Obesity and Metabolism 19 (1):125–32. doi: 10.1111/dom.12793.
   PubMed Web of Science ®Google Scholar
• Maersk, M., A. Belza, H. Stødkilde-Jørgensen, S. Ringgaard, E. Chabanova, H. Thomsen, S. B. Pedersen, A. Astrup, and B. Richelsen. 2012. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: A 6-mo randomized intervention study. The American Journal of Clinical Nutrition 95 (2):283–9. doi: 10.3945/ajcn.111.022533.
   PubMed Web of Science ®Google Scholar
• Maki, K. C., L. L. Curry, M. S. Reeves, P. D. Toth, J. M. McKenney, M. V. Farmer, S. L. Schwartz, B. C. Lubin, A. C. Boileau, M. R. Dicklin, et al. 2008. Chronic consumption of rebaudioside a, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food and Chemical Toxicology 46 (7):S47–S53. doi: 10.1016/j.fct.2008.05.007.
   PubMed Web of Science ®Google Scholar
• Mbambo, N. P., S. N. Dlamini, C. I. Chukwuma, and M. S. Islam. 2020. Comparative effects of commonly used commercially available non‐nutritive sweeteners on diabetes‐related parameters in non‐diabetic rats. Journal of Food Biochemistry 44 (11):e13453.
   PubMed Web of Science ®Google Scholar
• Mejia, E., and M. Pearlman. 2019. Natural alternative sweeteners and diabetes management. Current Diabetes Reports 19 (12):1–10. doi: 10.1007/s11892-019-1273-8.
   PubMed Web of Science ®Google Scholar
• Mooradian, A. D. 2009. Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology 5 (3):150–9. doi: 10.1038/ncpendmet1066.
   Google Scholar
• Moradinazar, M., Y. Pasdar, F. Najafi, S. Shahsavari, E. Shakiba, B. Hamzeh, and N. Fakhri. 2020. Association between dyslipidemia and blood lipids concentration with smoking habits in the kurdish population of iran. BMC Public Health 20 (1):1–10. doi: 10.1186/s12889-020-08809-z.
   PubMed Web of Science ®Google Scholar
• Mozaffarian, D., E. J. Benjamin, A. S. Go, D. K. Arnett, M. J. Blaha, M. Cushman, S. de Ferranti, J.-P. Després, H. J. Fullerton, V. J. Howard, et al. 2015. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131 (4):e29–e322. doi: 10.1161/CIR.0000000000000152.
   PubMed Web of Science ®Google Scholar
• Onakpoya, I. J., and C. J. Heneghan. 2015. Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: A systematic review and meta-analysis of randomised clinical trials. European Journal of Preventive Cardiology 22 (12):1575–87.
   PubMed Web of Science ®Google Scholar
• Pearlman, M., J. Obert, and L. Casey. 2017. The association between artificial sweeteners and obesity. Current Gastroenterology Reports 19 (12):64. doi: 10.1007/s11894-017-0602-9.
   PubMedGoogle Scholar
• Peters, J. C., J. Beck, M. Cardel, H. R. Wyatt, G. D. Foster, Z. Pan, A. C. Wojtanowski, S. S. Vander Veur, S. J. Herring, C. Brill, et al. 2016. The effects of water and non‐nutritive sweetened beverages on weight loss and weight maintenance: A randomized clinical trial. Obesity 24 (2):297–304. doi: 10.1002/oby.21327.
   PubMed Web of Science ®Google Scholar
• Peters, J. C., H. R. Wyatt, G. D. Foster, Z. Pan, A. C. Wojtanowski, S. S. Vander Veur, S. J. Herring, C. Brill, and J. O. Hill. 2014. The effects of water and non‐nutritive sweetened beverages on weight loss during a 12‐week weight loss treatment program. Obesity 22 (6):1415–21. doi: 10.1002/oby.20737.
   PubMed Web of Science ®Google Scholar
• Police, S. B., J. C. Harris, R. A. Lodder, and L. A. Cassis. 2009. Effect of diets containing sucrose vs. D‐tagatose in hypercholesterolemic mice. Obesity 17 (2):269–75.
   PubMed Web of Science ®Google Scholar
• Raben, A., B. Møller, A. Flint, T. Vasilaras, A. Christina Møller, J. Juul Holst, and A. Astrup. 2011. Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks’ sucrose-rich diet compared to an artificially sweetened diet: A randomised controlled trial. Food & Nutrition Research 55 (1):5961. doi: 10.3402/fnr.v55i0.5961.
   PubMed Web of Science ®Google Scholar
• Ritu, M., and J. Nandini. 2016. Nutritional composition of stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non‐insulin dependent diabetes mellitus. Journal of the Science of Food and Agriculture 96 (12):4231–4.
   PubMed Web of Science ®Google Scholar
• Sadeghi, O., K. Djafarian, S. Ghorabi, M. Khodadost, M. Nasiri, and S. Shab-Bidar. 2019. Dietary intake of fish, n-3 polyunsaturated fatty acids and risk of hip fracture: A systematic review and meta-analysis on observational studies. Critical Reviews in Food Science and Nutrition 59 (8):1320–33.
   PubMed Web of Science ®Google Scholar
• Santos, N. C., L. M. De Araujo, G. De Luca Canto, E. N. S. Guerra, M. S. Coelho, and M. D. F. Borin. 2018. Metabolic effects of aspartame in adulthood: A systematic review and meta-analysis of randomized clinical trials. Critical Reviews in Food Science and Nutrition 58 (12):2068–81.
   PubMed Web of Science ®Google Scholar
• Shi, J., Y. Bai, S. Qiu, Y. Li, C. Kou, Y. Tao, Q. Zhen, Y. Gu, Y. Yu, K. Zhang, et al. 2018. Classified status of smoking and quitting has different associations with dyslipidemia in residents in Northeast China. Clinica Chimica Acta; International Journal of Clinical Chemistry 486:209–13. doi: 10.1016/j.cca.2018.08.001.
   PubMed Web of Science ®Google Scholar
• Silva, G. E. C. D., A. H. Assef, C. C. Albino, LDaF. Ferri, G. Tasin, M. H. Takahashi, W. E. Filho, and R. B. Bazotte. 2006. Investigation of the tolerability of oral stevioside in Brazilian hyperlipidemic patients. Brazilian Archives of Biology and Technology 49 (4):583–7. doi: 10.1590/S1516-89132006000500007.
   Web of Science ®Google Scholar
• Smith, G. 2007. Epidemiology of dyslipidemia and economic burden on the healthcare system. American Journal of Managed Care 13 (3):S68.
   PubMed Web of Science ®Google Scholar
• Sørensen, L. B., A. Raben, S. Stender, and A. Astrup. 2005. Effect of sucrose on inflammatory markers in overweight humans. The American Journal of Clinical Nutrition 82 (2):421–7. doi: 10.1093/ajcn/82.2.421.
   PubMed Web of Science ®Google Scholar
• Stern, S. B., S. Bleicher, A. Flores, G. Gombos, D. Recitas, and J. Shu. 1976. Administration of aspartame in non‐insulin‐dependent diabetics. Journal of Toxicology and Environmental Health 2 (2):429–39. doi: 10.1080/15287397609529444.
   PubMed Web of Science ®Google Scholar
• Tan, X., G. Jiao, Y. Ren, X. Gao, Y. Ding, X. Wang, and H. Xu. 2008. Relationship between smoking and dyslipidemia in western Chinese elderly males. Journal of Clinical Laboratory Analysis 22 (3):159–63.
   PubMed Web of Science ®Google Scholar
• Van Rompay, M. I., N. M. Mckeown, C. Castaneda-Sceppa, J. M. Ordovás, and K. L. Tucker. 2013. Carbohydrate nutrition differs by diabetes status and is associated with dyslipidemia in Boston Puerto Rican adults without diabetes. The Journal of Nutrition 143 (2):182–8. doi: 10.3945/jn.112.168914.
   PubMed Web of Science ®Google Scholar
• Warrington, S., C. Lee, A. Otabe, T. Narita, O. Polnjak, V. Pirags, and D. Krievins. 2011. Acute and multiple-dose studies to determine the safety, tolerability, and pharmacokinetic profile of advantame in healthy volunteers. Food and Chemical Toxicology 49:S77–S83. doi: 10.1016/j.fct.2011.06.043.
   PubMed Web of Science ®Google Scholar
• Welsh, J. A., A. Sharma, J. L. Abramson, V. Vaccarino, C. Gillespie, and M. B. Vos. 2010. Caloric sweetener consumption and dyslipidemia among us adults. Jama 303 (15):1490–7. doi: 10.1001/jama.2010.449.
   PubMed Web of Science ®Google Scholar
• Zahedi, H., S. Djalalinia, O. Sadeghi, H. Asayesh, M. Noroozi, A. M. Gorabi, R. Mohammadi, and M. Qorbani. 2018. Dietary inflammatory potential score and risk of breast cancer: Systematic review and meta-analysis. Clinical Breast Cancer 18 (4):e561–e70.
   PubMed Web of Science ®Google Scholar
• Zhang, D., G. Wang, J. Fang, and C. Mercado. 2017. Hyperlipidemia and medical expenditures by cardiovascular disease status in us adults. Medical Care 55 (1):4–11.
   PubMed Web of Science ®Google Scholar